VUNO Med®-LungCT AI™
VUNO
Product specifications |
Information source:
Vendor
Last updated: July 12, 2020 |
General | |
---|---|
Product name | VUNO Med®-LungCT AI™ |
Company | VUNO |
Subspeciality | Chest |
Modality | CT |
Disease targeted | Lung Cancer |
Key-features | Nodule detection, Nodule measurement, Nodule classification, Lung-RADS reporting |
Suggested use | Before: adapting worklist order During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion |
Data characteristics | |
Population | All lung cancer screening population |
Input | Low-dose Lung CT Scan |
Input format | DICOM |
Output | List of detected nodules, Nodule diameter/volume, Nodule types, Nodule growth |
Output format | DICOM, PDF |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 10 - 60 seconds |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 06-2020 |
Distribution channels | |
Countries present (clinical, non-research use) | 10+ |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use |
Based on | Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |
|